%0 Journal Article %@ 1929-0748 %I JMIR Publications %V 7 %N 4 %P e109 %T Safer Prescribing and Care for the Elderly (SPACE): Protocol of a Cluster Randomized Controlled Trial in Primary Care %A Wallis,Katharine Ann %A Elley,Carolyn Raina %A Lee,Arier %A Moyes,Simon %A Kerse,Ngaire %+ Department of General Practice and Primary Health Care, University of Auckland, 261 Morrin Road, Auckland, 1142, New Zealand, 64 9 923 9161, k.wallis@auckland.ac.nz %K general practice %K safety %K prescriptions %K multimorbidity %K polypharmacy %K adverse drug events %D 2018 %7 26.04.2018 %9 Protocol %J JMIR Res Protoc %G English %X Background: High-risk prescribing, adverse drug events, and avoidable adverse drug event hospitalizations are common. The single greatest risk factor for high-risk prescribing and adverse drug events is the number of medications a person is taking. More people are living longer and taking more medications for multiple long-term conditions. Most on-going prescribing occurs in primary care. The most effective, cost-effective, and practical approach to safer prescribing in primary care is not yet known. Objective: To test the effect of the Safer Prescribing And Care for the Elderly (SPACE) intervention on high-risk prescribing of nonsteroidal anti-inflammatory and antiplatelet medicines, and related adverse drug event hospitalizations. Methods: This is a protocol of a cluster randomized controlled trial. The clusters will be primary care practices. Data collection and analysis will be at the level of patient. Results: Recruitment started in 2018. Six-month data collection will be in 2018. Conclusions: This study addresses an important translational gap, testing an intervention designed to prompt medicines review and support safer prescribing in routine primary care practice. Trial Registration: Australian New Zealand Clinical Trials Registry: ACTRN12618000034235 http://www.ANZCTR.org.au/ACTRN12618000034235.aspx (Archived with Webcite at http://www.webcitation.org/6yj9RImDf) %M 29699966 %R 10.2196/resprot.9839 %U http://www.researchprotocols.org/2018/4/e109/ %U https://doi.org/10.2196/resprot.9839 %U http://www.ncbi.nlm.nih.gov/pubmed/29699966